Differentiate between DiGeorge and Omenn syndromes.

Differentiate between DiGeorge and Omenn syndromes.

• A. DiGeorge: thymus present but T cells functional; Omenn: Rag gene defect leads to partial B/T cell deficiency
• B. DiGeorge: B cell deficiency; Omenn: T cell deficiency
• C. DiGeorge: no thymus and no T cell development; Omenn: no Rag protein so no B or T cell development
• D. DiGeorge: autoimmune syndrome; Omenn: autoinflammatory syndrome

Answer: (C)

Lymphocyte development hinges on where the block occurs in the immune system. In DiGeorge syndrome, the problem is failure of thymic development due to 3rd and 4th pharyngeal pouch defects, leading to thymic aplasia or hypoplasia. Without a proper thymus, T cell maturation is severely impaired, so peripheral T cells are markedly reduced (and helper T–cell–dependent B cell responses are compromised), even though B cells can be present. In Omenn syndrome, the issue lies in defective V(D)J recombination caused by mutations in recombination-activating genes (RAG1/RAG2) or other components. This blocks the generation of diverse B and T cell receptors, so very few B and T cells develop, and the few that do are often oligoclonal and dysfunctional. Clinically, this presents as a form of SCID with widespread immune dysregulation. So the key difference is DiGeorge blocks T cell development at the thymus level, whereas Omenn (RAG-related) blocks B and T cell development at the level of receptor gene rearrangement.

Lymphocyte development hinges on where the block occurs in the immune system. In DiGeorge syndrome, the problem is failure of thymic development due to 3rd and 4th pharyngeal pouch defects, leading to thymic aplasia or hypoplasia. Without a proper thymus, T cell maturation is severely impaired, so peripheral T cells are markedly reduced (and helper T–cell–dependent B cell responses are compromised), even though B cells can be present.

In Omenn syndrome, the issue lies in defective V(D)J recombination caused by mutations in recombination-activating genes (RAG1/RAG2) or other components. This blocks the generation of diverse B and T cell receptors, so very few B and T cells develop, and the few that do are often oligoclonal and dysfunctional. Clinically, this presents as a form of SCID with widespread immune dysregulation.

So the key difference is DiGeorge blocks T cell development at the thymus level, whereas Omenn (RAG-related) blocks B and T cell development at the level of receptor gene rearrangement.